HIND
Vyome Holdings, IncCompany Information
- Company Name
- Vyome Holdings, Inc
- CIK
- CIK0001427570
- Category
- <br>Emerging growth company
- Ticker: Exchange
- HIND: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- HIND
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-06-30
- Last sale
- 2024-05-31
- Shares purchased (TTM)
- 17,702
- Shares sold (TTM)
- 383
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 117,742
- Shares outstanding
- 7,018,528
- Ownership
- 1.68%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series C Convertible Preferred Stock | - | - | - | - | - | 10 | 10 | 0 | 0 | 0 | 10 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 8 | 9 | 5 | 6 | 4 | 3 | 0 | 1 | 1 | 2 | 4 | 1 | ||||||
| Restricted Cash | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts And Other Receivables Net Current | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | ||||||
| Notes And Loans Receivable Net Current | - | - | - | - | 1 | - | - | - | - | - | - | - | ||||||
Assets | ||||||||||||||||||
| Deferred Offering Costs | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | - | 0 | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Other Assets Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Assets Current | 8 | 9 | 5 | 6 | 9 | 6 | 0 | 5 | 6 | 8 | 10 | 7 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Inventory Net | - | - | - | - | 3 | 3 | 2 | 3 | 3 | 3 | 4 | 3 | ||||||
| Prepaid Expense And Other Assets Current | - | - | - | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Prepaid Expense Noncurrent | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Tax Assets Net | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Assets Noncurrent | 1 | 1 | 1 | 1 | - | - | 1 | - | - | - | - | - | ||||||
| Assets | 9 | 10 | 6 | 7 | 9 | 1 | 1 | 1 | 6 | 8 | 11 | 8 | ||||||
Liabilities Current | ||||||||||||||||||
| Other Assets Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Shareholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 2 | - | - | 1 | - | - | - | - | - | ||||||
| Accounts Payable Current | - | - | 1 | - | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 1 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | - | - | 1 | - | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 3 | ||||||
| Employee Related Liabilities Current | 0 | 1 | 1 | 1 | - | - | 1 | - | - | - | - | - | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Debt Current | - | - | - | - | - | - | 1 | - | - | - | - | - | ||||||
| Convertible Debt Current | - | - | - | - | - | - | 4 | - | - | - | - | - | ||||||
| Liabilities Current | 2 | 2 | 3 | 3 | 3 | 4 | 6 | 4 | 3 | 4 | 4 | 4 | ||||||
| Liabilities | 2 | 2 | 3 | 3 | 3 | 5 | 6 | 4 | 3 | 4 | 4 | 5 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Warrants And Rights Outstanding | - | - | - | - | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Noncurrent | - | - | - | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 95 | 95 | 90 | 89 | 650 | 643 | 51 | 643 | 642 | 642 | 642 | 637 | ||||||
| Minority Interest | 1 | 1 | 1 | 1 | - | - | 0 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -89 | -89 | -88 | -86 | -644 | -641 | -55 | -641 | -639 | -638 | -636 | -634 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Stockholders Equity | 7 | 8 | 4 | 3 | 6 | 1 | -4 | 1 | 3 | 5 | 7 | 3 | ||||||
| Liabilities And Stockholders Equity | 9 | 10 | 6 | 7 | 9 | 6 | 1 | 6 | 6 | 8 | 11 | 8 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | 10 | - | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | 0.00 | - | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Issued | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Vyome Holdings Inc | - | - | - | 6 | - | - | - | - | - | - | - | - | ||||||
| Vyome Therapeutics Inc | 0 | 20 | 16 | 0 | - | - | 16 | - | - | - | - | - | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 7 | 7 | 6 | - | 3 | 0 | 0 | 1 | 29 | 23 | 0 | 3 | ||||||
| Shares Outstanding | 7 | 7 | 6 | - | 3 | 0 | 0 | 1 | 29 | 23 | 0 | 3 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVyome Holdings, Inc (HIND) — SEC Financial Statements & Analysis
Vyome Holdings, Inc (HIND) is a pharmaceutical preparations company, incorporated in DE. Vyome Holdings, Inc trades on Nasdaq as: HIND. Vyome Holdings, Inc (HIND)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Vyome Holdings, Inc carries a market cap of $15.09M, a P/E ratio of -1.33x, a P/B ratio of 2.06x, a P/S ratio of -7.63x, an enterprise value of $7.20M, and an EV/EBITDA multiple of -0.60x. On profitability, it posts a gross margin of -3.46%, an operating margin of 603.11%, a net margin of 572.04%, a Return on Equity (ROE) of -975.67%, a Return on Assets (ROA) of -124.23%, and a Return on Invested Capital (ROIC) of -24531.11%. Per share, it reports EPS of $-1.61, diluted EPS of $-1.98, free cash flow per share of $-0.79, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 52.40% year-over-year, net income growth of -1054.61% year-over-year, and EPS growth of -152.50% year-over-year. On the balance sheet, it maintains a current ratio of 4.37x, a quick ratio of 4.32x, working capital of $6.29M, a debt-to-equity ratio of 0.26x, a debt ratio of 0.2, an interest coverage ratio of -285.77x, free cash flow of $-5.58M (TTM), and net debt of $-7.89M. Figures sourced from SEC EDGAR.
- Market Cap
- $15.09M
- P/E TTM
- -1.33x
- EPS TTM
- $-1.61
- P/B TTM
- 2.06x
- ROE TTM
- -975.67%
- ROA TTM
- -124.23%
- Debt To Equity
- 0.26x
- Free Cash Flow TTM
- $-5.58M
- Net Revenue TTM Growth 1Y
- 52.40%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Vyome Holdings, Inc in?
Vyome Holdings, Inc (HIND) operates in the Pharmaceutical Preparations industry.
What exchange does HIND trade on?
Vyome Holdings, Inc (HIND) trades on the Nasdaq.
Where is Vyome Holdings, Inc incorporated?
Vyome Holdings, Inc is incorporated in DE.
When was Vyome Holdings, Inc (HIND)'s most recent SEC filing?
Vyome Holdings, Inc (HIND)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is HIND's market cap?
Vyome Holdings, Inc (HIND) has a market capitalization of $15.09M as of 2026-06-30.
What is HIND's EPS (earnings per share)?
Vyome Holdings, Inc (HIND)'s trailing twelve month EPS is $-1.61 as of 2026-06-30.
What is HIND's ROE (return on equity)?
Vyome Holdings, Inc (HIND)'s trailing twelve month Return on Equity (ROE) is -975.67% as of 2026-06-30.
What is HIND's ROA (return on assets)?
Vyome Holdings, Inc (HIND)'s trailing twelve month Return on Assets (ROA) is -124.23% as of 2026-06-30.
What is HIND's ROIC (return on invested capital)?
Vyome Holdings, Inc (HIND)'s trailing twelve month Return on Invested Capital (ROIC) is -24531.11% as of 2025-12-31.
What is HIND's EV/EBITDA?
Vyome Holdings, Inc (HIND)'s trailing twelve month EV/EBITDA is -0.60x as of 2026-06-30.